Lorraine Beldotti

719 total citations
13 papers, 541 citations indexed

About

Lorraine Beldotti is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Lorraine Beldotti has authored 13 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Lorraine Beldotti's work include Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Lorraine Beldotti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Lorraine Beldotti collaborates with scholars based in United States and Canada. Lorraine Beldotti's co-authors include Robert S. Schwartz, Martine Y. K. Armstrong, J André-Schwartz, William Dameshek, Ernst Gleichmann, Helga Gleichmann, Robert M. Lewis, A Müftüoğlu, Kyoichi Kano and Felix Milgrom and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Blood.

In The Last Decade

Lorraine Beldotti

12 papers receiving 405 citations

Peers

Lorraine Beldotti
Guy S. Perry United States
R S Metzgar United States
L J Nineham United States
Leroy Fass United States
T Shibuya Japan
N Carpentier Switzerland
Guy S. Perry United States
Lorraine Beldotti
Citations per year, relative to Lorraine Beldotti Lorraine Beldotti (= 1×) peers Guy S. Perry

Countries citing papers authored by Lorraine Beldotti

Since Specialization
Citations

This map shows the geographic impact of Lorraine Beldotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Beldotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Beldotti more than expected).

Fields of papers citing papers by Lorraine Beldotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Beldotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Beldotti. The network helps show where Lorraine Beldotti may publish in the future.

Co-authorship network of co-authors of Lorraine Beldotti

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Beldotti. A scholar is included among the top collaborators of Lorraine Beldotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Beldotti. Lorraine Beldotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Shumak, Kenneth H., et al.. (1979). Diagnosis of Haematological Disease using Anti‐i. British Journal of Haematology. 41(3). 399–405. 2 indexed citations
2.
Shumak, Kenneth H., et al.. (1979). Diagnosis of Haematological Disease using Anti‐i. British Journal of Haematology. 41(3). 407–411. 8 indexed citations
3.
Kano, Kyoichi, Lorraine Beldotti, Felix Milgrom, & Robert S. Schwartz. (1974). Glomerulonephritis in the Graft-vs-Host Reaction: Serologic Demonstration of Anti-Host Antibodies. The Journal of Immunology. 112(1). 410–412. 14 indexed citations
4.
Armstrong, Martine Y. K., Ernst Gleichmann, Helga Gleichmann, et al.. (1970). CHRONIC ALLOGENEIC DISEASE. The Journal of Experimental Medicine. 132(3). 417–439. 87 indexed citations
5.
Lewis, Robert M., Martine Y. K. Armstrong, J André-Schwartz, et al.. (1968). CHRONIC ALLOGENEIC DISEASE. The Journal of Experimental Medicine. 128(4). 653–679. 68 indexed citations
6.
André-Schwartz, J, et al.. (1967). Neoplastic sequelae of allogeneic disease. Transplantation. 5(6). 1542–1542. 2 indexed citations
7.
André-Schwartz, J, et al.. (1967). Neoplastic sequelae of allogenic disease. II. Electron-microscopic study of a neoplasm (reticuloendotheliosis) in survivors of the graft-vs.-host reaction.. PubMed. 50(5). 707–44. 8 indexed citations
8.
Armstrong, Martine Y. K., Robert S. Schwartz, & Lorraine Beldotti. (1967). NEOPLASTIC SEQUELAE OF ALLOGENEIC DISEASE III. HISTOLOGICAL EVENTS FOLLOWING TRANSPLANTATION OF ALLOGENEIC SPLEEN CELLS. Transplantation. 5(6). 1380–1392. 27 indexed citations
9.
Schwartz, Robert S., J André-Schwartz, Martine Y. K. Armstrong, & Lorraine Beldotti. (1966). NEOPLASTIC SEQUELAE OF ALLOGENIC DISEASE. I. THEORETICAL CONSIDERATIONS AND EXPERIMENTAL DESIGN*. Annals of the New York Academy of Sciences. 129(1). 804–821. 45 indexed citations
10.
Schwartz, Robert S. & Lorraine Beldotti. (1965). THE TREATMENT OF CHRONIC MURINE HOMOLOGOUS DISEASE. Transplantation. 3(1). 79–97. 13 indexed citations
11.
Schwartz, Robert S. & Lorraine Beldotti. (1965). Malignant Lymphomas Following Allogenic Disease: Transition from an Immunological to a Neoplastic Disorder. Science. 149(3691). 1511–1514. 166 indexed citations
12.
Schwartz, Robert S. & Lorraine Beldotti. (1963). Homologous Disease Reactivation by X-radiation. Science. 140(3563). 171–172. 12 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026